BackPaxMedica Overview

PaxMedica Total Current Liabilities

Track PaxMedica's total current liabilities ($2.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$2.11M
↓ 13.11% YoYΔ $-317941.00 vs prior year quarter

Peer average

Loading

PaxMedica Total Current Liabilities History

Loading

PaxMedica vs. peers: Total Current Liabilities Comparison

Loading

PaxMedica Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PaxMedica (PXMD) FAQ

PaxMedica (PXMD) currently reports a total current liabilities of $2.1M as of June 2024. That compares with $2.4M in the prior-year period — down 13.1% year over year. Use the charts on this page to explore PaxMedica's total current liabilities history and peer comparisons.

PaxMedica's total current liabilities decreased from $2.4M to $2.1M — a 13.1% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PaxMedica reported $2.1M in total current liabilities as of June 2024. That compares with $2.4M in the prior-year period — down 13.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $2.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PaxMedica, and consider following PXMD for alerts when major investors trade the stock.